The contributions of particular MYC family proteins in different cancers parallel their developmental expression, with deregulation of MYC in diverse hematologic and solid tumors, deregulation of MYCN mainly in neuroendocrine and neuronal tumors, and deregulation of MYCL in small cell lung carcinoma (SCLC) (5). The gene discussed is MYCN; the disease is cancer.